Roughly 100 peptide drugs are already approved; 150 more are in trials. The real near-term promise is in metabolism, infectious disease, diagnostics, and cancer. The irony: the uses most aggressively marketed in the wellness world — brain boosting, recovery, tissue repair — are exactly where peptides face the most difficult scientific barriers.